BioNTech Eyes Cancer Vaccines by 2030

The company behind one of the most successful COVID-19 vaccines wants to use their mRNA technology to take on cancer.

Bbc
BBC

BioNtech and Pfizer teamed up for one of the most successful vaccination campaigns in history. Now, according to a recent Interesting Engineering article, BioNTech says it has made breakthroughs that could lead to cancer vaccines in the near future. Professors Uğur Şahin and Özlem Türeci, the husband and wife team behind BioNTech, believe the mRNA technology used for their COVID-19 vaccine could be tweaked to make the immune system attack cancer cells rather than coronaviruses as soon as 2030.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report